miR-1 also has a tumor suppressor function in colorectal cancer by directly downregulating the MET oncogene both at RNA and protein level, and reexpression of miR-1 leads to MET-driven reduction of cell proliferation and motility, identifying the miR-1 downmodulation as one of the events that could enhance colorectal cancer progression [44]. Here, MET is linked to colorectal cancer.